Related Experiment Video

Updated: Apr 15, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K

Postconditioning attenuates early ventricular arrhythmias in patients with high-risk ST-segment elevation myocardial

Aleksander Araszkiewicz1, Marek Grygier1, Małgorzata Pyda1

  • 11st Department of Cardiology, University of Medical Sciences, Poznan, Poland.

Journal of Cardiology
|April 2, 2015
PubMed

Insights

Postconditioning (postcon) significantly reduced malignant ventricular arrhythmias (VA) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). This finding suggests postcon may be a protective strategy against early VA in STEMI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • Postconditioning (postcon) is known to protect against ischemia-reperfusion injury in ST-segment elevation myocardial infarction (STEMI).
  • The effect of postcon on early malignant ventricular arrhythmias (VA) in STEMI patients undergoing primary percutaneous coronary intervention (PCI) remains unclear.
  • This study investigates whether postcon can reduce the incidence of VA in high-risk STEMI patients.

Purpose of the Study:

  • To evaluate the influence of postconditioning on the occurrence of ventricular arrhythmias (VA) in STEMI patients.
  • To assess the efficacy of postcon as a protective strategy against early malignant VA following primary PCI.
  • To determine if postcon can mitigate ischemia-reperfusion injury-related arrhythmias in STEMI.

Main Methods:

  • Seventy-five STEMI patients treated with primary PCI within 6 hours of symptom onset were randomized into postcon (n=37) and control (n=38) groups.
  • Postconditioning involved brief, repeated inflation/deflation cycles of the angioplasty balloon immediately after reperfusion.
  • Continuous electrocardiographic monitoring for 48 hours assessed the primary endpoint: occurrence of VA (VF, sVT, nsVT).

Main Results:

  • The incidence of VA was significantly lower in the postcon group (48.6%) compared to the control group (76.3%) (p=0.013).
  • Specifically, ventricular fibrillation (VF) occurred in 3 postcon patients versus 2 controls, and sustained ventricular tachycardia (sVT) in 0 postcon patients versus 4 controls.
  • Non-sustained ventricular tachycardia (nsVT) occurred in 15 postcon patients versus 23 controls.

Conclusions:

  • Postconditioning may significantly reduce the occurrence of malignant ventricular arrhythmias (VA) in STEMI patients treated with primary PCI.
  • This suggests postcon could be a valuable therapeutic intervention to prevent early VA and potentially reduce infarct size.
  • Further research is warranted to confirm these findings and explore the underlying mechanisms.
Abstract

Keywords:
Myocardial infarctionPostconditioningVentricular arrhythmias

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

9.0K

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.1K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.2K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K